Genelux Corporation | Redefining Immuno-Oncology
Genelux is a clinical-stage biopharmaceutical company evaluating a flexible and powerful therapeutic modality with the potential to redefine immuno-oncology.
Keywords:
clinical trials, genelux, genelux corporation, genelux stock, genelux san diego, genelux financials
Created: | 2002-08-22 |
Expires: | 2023-08-22 |
Owner: | Registration Private (Domains By Proxy, LLC) |
Hosting company: | Hostwinds LLC. |
Registrar: | GODADDY.COM, LLC |
IPs: | 23.254.134.180 |
DNS: |
ns1.dns.i2bnetworks.com ns2.dns.i2bnetworks.com ns3.dns.i2bnetworks.com |
Email: | See owner's emails |